FDA Approves Ubrelvy for Acute Migraine Treatment
Significantly more patients treated with Ubrelvy versus placebo achieved pain freedom two hours post-treatment TUESDAY, Dec. 24, 2019 (HealthDay News) — Ubrelvy (ubrogepant) tablets have been approved for acute treatment...
Read More